{"id":"https://openalex.org/W4225877081","doi":"https://doi.org/10.7150/thno.64233","title":"Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules","display_name":"Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules","alternate_titles":[],"publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4225877081","doi":"https://doi.org/10.7150/thno.64233","pmid":"https://pubmed.ncbi.nlm.nih.gov/35265218","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8899577"},"language":"en","primary_location":{"id":"doi:10.7150/thno.64233","doi":"https://doi.org/10.7150/thno.64233","is_oa":true,"landing_page_url":"https://doi.org/10.7150/thno.64233","pdf_url":"https://www.thno.org/v12p2427.pdf","source":{"id":"https://openalex.org/S2482500137","display_name":"Theranostics","issn_l":"1838-7640","issn":["1838-7640"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317973","host_organization_name":"Ivyspring International Publisher","host_organization_lineage":["https://openalex.org/P4310317973"],"host_organization_lineage_names":["Ivyspring International Publisher"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Theranostics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4225877081"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.thno.org/v12p2427.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065570082","display_name":"Elisabetta Valentini","orcid":"https://orcid.org/0000-0003-3073-3590","observed_orcids":["https://orcid.org/0000-0003-3073-3590"]},"institutions":[{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisabetta Valentini","raw_affiliation_strings":["Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070564127","display_name":"Simona D\u2019Aguanno","orcid":"https://orcid.org/0000-0002-1224-4454","observed_orcids":["https://orcid.org/0000-0002-1224-4454"]},"institutions":[{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona D'Aguanno","raw_affiliation_strings":["Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046069046","display_name":"Marta Di Martile","orcid":"https://orcid.org/0000-0001-9924-9022","observed_orcids":["https://orcid.org/0000-0001-9924-9022"]},"institutions":[{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marta Di Martile","raw_affiliation_strings":["Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022948682","display_name":"Camilla Montesano","orcid":"https://orcid.org/0000-0001-7721-4961","observed_orcids":["https://orcid.org/0000-0001-7721-4961"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Camilla Montesano","raw_affiliation_strings":["Department of Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033258883","display_name":"Virginia Ferraresi","orcid":"https://orcid.org/0000-0001-6419-1668","observed_orcids":["https://orcid.org/0000-0001-6419-1668"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Virginia Ferraresi","raw_affiliation_strings":["Sarcomas and Rare Tumours Departmental Unit- IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcomas and Rare Tumours Departmental Unit- IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029243964","display_name":"Alexandros Patsilinakos","orcid":"https://orcid.org/0000-0001-5961-3328","observed_orcids":["https://orcid.org/0000-0001-5961-3328"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alexandros Patsilinakos","raw_affiliation_strings":["Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]},{"raw_affiliation_string":"Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023601801","display_name":"Manuela Sabatino","orcid":"https://orcid.org/0000-0001-9127-3925","observed_orcids":["https://orcid.org/0000-0001-9127-3925"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Manuela Sabatino","raw_affiliation_strings":["Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]},{"raw_affiliation_string":"Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001505294","display_name":"Lorenzo Antonini","orcid":"https://orcid.org/0000-0003-3662-9241","observed_orcids":["https://orcid.org/0000-0003-3662-9241"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lorenzo Antonini","raw_affiliation_strings":["Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]},{"raw_affiliation_string":"Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072124534","display_name":"Martina Chiacchiarini","orcid":"https://orcid.org/0000-0001-9229-0372","observed_orcids":["https://orcid.org/0000-0001-9229-0372"]},"institutions":[{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Martina Chiacchiarini","raw_affiliation_strings":["Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084101516","display_name":"S\u00e9rgio Valente","orcid":"https://orcid.org/0000-0002-2241-607X","observed_orcids":["https://orcid.org/0000-0002-2241-607X"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sergio Valente","raw_affiliation_strings":["Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012839091","display_name":"Antonello Mai","orcid":"https://orcid.org/0000-0001-9176-2382","observed_orcids":["https://orcid.org/0000-0001-9176-2382"]},"institutions":[{"id":"https://openalex.org/I4210153523","display_name":"Istituto Pasteur","ror":"https://ror.org/051v7w268","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210153523"]},{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonello Mai","raw_affiliation_strings":["Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","Pasteur Institute, Cenci Bolognetti Foundation, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy.; Pasteur Institute, Cenci Bolognetti Foundation, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]},{"raw_affiliation_string":"Pasteur Institute, Cenci Bolognetti Foundation, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I4210153523","https://openalex.org/I861853513"]},{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy.; Pasteur Institute, Cenci Bolognetti Foundation, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I4210153523","https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072838208","display_name":"Gianni Colotti","orcid":"https://orcid.org/0000-0002-9913-0635","observed_orcids":["https://orcid.org/0000-0002-9913-0635"]},"institutions":[{"id":"https://openalex.org/I4210110528","display_name":"Institute of Molecular Biology and Pathology","ror":"https://ror.org/01nyatq71","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210110528","https://openalex.org/I4210155236"]},{"id":"https://openalex.org/I4210155236","display_name":"National Research Council","ror":"https://ror.org/04zaypm56","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210155236"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianni Colotti","raw_affiliation_strings":["Institute of Molecular Biology and Pathology, Italian National Research Council, Piazzale A.Moro 5, 20 Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular Biology and Pathology, Italian National Research Council, Piazzale A.Moro 5, 20 Rome, Italy","institution_ids":["https://openalex.org/I4210110528","https://openalex.org/I4210155236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003256018","display_name":"Rino Ragno","orcid":"https://orcid.org/0000-0001-5399-975X","observed_orcids":["https://orcid.org/0000-0001-5399-975X"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Rino Ragno","raw_affiliation_strings":["Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Chemistry, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]},{"raw_affiliation_string":"Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011256939","display_name":"Daniela Trisciuoglio","orcid":"https://orcid.org/0000-0002-7007-7914","observed_orcids":["https://orcid.org/0000-0002-7007-7914"]},"institutions":[{"id":"https://openalex.org/I4210110528","display_name":"Institute of Molecular Biology and Pathology","ror":"https://ror.org/01nyatq71","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210110528","https://openalex.org/I4210155236"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210155236","display_name":"National Research Council","ror":"https://ror.org/04zaypm56","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210155236"]},{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Daniela Trisciuoglio","raw_affiliation_strings":["Institute of Molecular Biology and Pathology, Italian National Research Council, Piazzale A.Moro 5, 20 Rome, Italy","Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","Institute of Molecular Biology and Pathology, Italian National Research Council, Piazzale A.Moro 5, 20 Rome, Italy.; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular Biology and Pathology, Italian National Research Council, Piazzale A.Moro 5, 20 Rome, Italy","institution_ids":["https://openalex.org/I4210110528","https://openalex.org/I4210155236"]},{"raw_affiliation_string":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]},{"raw_affiliation_string":"Institute of Molecular Biology and Pathology, Italian National Research Council, Piazzale A.Moro 5, 20 Rome, Italy.; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210110528","https://openalex.org/I4210155236","https://openalex.org/I4387152244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086541444","display_name":"Donatella Del Bufalo","orcid":"https://orcid.org/0000-0002-3148-6096","observed_orcids":["https://orcid.org/0000-0002-3148-6096"]},"institutions":[{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Donatella Del Bufalo","raw_affiliation_strings":["Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, Italy","institution_ids":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5003256018","https://openalex.org/A5011256939","https://openalex.org/A5086541444"],"corresponding_institution_ids":["https://openalex.org/I4210110528","https://openalex.org/I4210153126","https://openalex.org/I4210155236","https://openalex.org/I4387152244","https://openalex.org/I861853513"],"apc_list":{"value":2500,"currency":"AUD","value_usd":1671},"apc_paid":{"value":2500,"currency":"AUD","value_usd":1671},"fwci":2.9008,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.93436712,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"12","issue":"5","first_page":"2427","last_page":"2444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.913100004196167,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.913100004196167,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.07769999653100967,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.968999981880188},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.8529999852180481},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.8640000224113464},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":1.0},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.5460000038146973},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.5320000052452087},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":1.0},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.7540000081062317},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5751182436943054},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5327235460281372},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.5132167339324951},{"id":"https://openalex.org/C149150037","wikidata":"https://www.wikidata.org/wiki/Q554446","display_name":"Bcl-2 family","level":4,"score":0.48548105359077454},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.4850129783153534},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.45251229405403137},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.44971948862075806},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.4473240077495575},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4028451442718506},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.38338539004325867},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3513000011444092},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22445976734161377},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.21602749824523926},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20818853378295898},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.18140321969985962},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.14942830801010132},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0878261923789978},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069550","descriptor_name":"Machine Learning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.7150/thno.64233","doi":"https://doi.org/10.7150/thno.64233","is_oa":true,"landing_page_url":"https://doi.org/10.7150/thno.64233","pdf_url":"https://www.thno.org/v12p2427.pdf","source":{"id":"https://openalex.org/S2482500137","display_name":"Theranostics","issn_l":"1838-7640","issn":["1838-7640"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317973","host_organization_name":"Ivyspring International Publisher","host_organization_lineage":["https://openalex.org/P4310317973"],"host_organization_lineage_names":["Ivyspring International Publisher"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Theranostics","raw_type":"journal-article"},{"id":"pmid:35265218","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35265218","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Theranostics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8899577","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8899577/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Theranostics","raw_type":"Text"},{"id":"pmh:oai:iris.uniroma1.it:11573/1623442","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11573/1623442","pdf_url":"https://iris.uniroma1.it/bitstream/11573/1623442/3/Valentini_Targeting_2022.pdf","source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.7150/thno.64233","doi":"https://doi.org/10.7150/thno.64233","is_oa":true,"landing_page_url":"https://doi.org/10.7150/thno.64233","pdf_url":"https://www.thno.org/v12p2427.pdf","source":{"id":"https://openalex.org/S2482500137","display_name":"Theranostics","issn_l":"1838-7640","issn":["1838-7640"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317973","host_organization_name":"Ivyspring International Publisher","host_organization_lineage":["https://openalex.org/P4310317973"],"host_organization_lineage_names":["Ivyspring International Publisher"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Theranostics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2771118284","display_name":null,"funder_award_id":"24942","funder_id":"https://openalex.org/F4320324143","funder_display_name":"Fondazione Italiana per la Ricerca sul Cancro"},{"id":"https://openalex.org/G8149753030","display_name":null,"funder_award_id":"24315","funder_id":"https://openalex.org/F4320324143","funder_display_name":"Fondazione Italiana per la Ricerca sul Cancro"}],"funders":[{"id":"https://openalex.org/F4320324143","display_name":"Fondazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4225877081.pdf","grobid_xml":"https://content.openalex.org/works/W4225877081.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W1563543222","https://openalex.org/W1834626755","https://openalex.org/W1971038977","https://openalex.org/W1971435587","https://openalex.org/W1976197588","https://openalex.org/W1979318103","https://openalex.org/W1999680285","https://openalex.org/W2007521899","https://openalex.org/W2014975424","https://openalex.org/W2030074887","https://openalex.org/W2049595905","https://openalex.org/W2064889319","https://openalex.org/W2087057672","https://openalex.org/W2096541451","https://openalex.org/W2124185479","https://openalex.org/W2127442706","https://openalex.org/W2141715738","https://openalex.org/W2148578446","https://openalex.org/W2150680216","https://openalex.org/W2172242534","https://openalex.org/W2174195550","https://openalex.org/W2263098711","https://openalex.org/W2287506006","https://openalex.org/W2289732339","https://openalex.org/W2297209675","https://openalex.org/W2336890914","https://openalex.org/W2409493795","https://openalex.org/W2472839297","https://openalex.org/W2557643461","https://openalex.org/W2589496748","https://openalex.org/W2591966157","https://openalex.org/W2616358207","https://openalex.org/W2735901092","https://openalex.org/W2737253335","https://openalex.org/W2743954912","https://openalex.org/W2758591336","https://openalex.org/W2766023905","https://openalex.org/W2769631482","https://openalex.org/W2774687487","https://openalex.org/W2775676664","https://openalex.org/W2784759345","https://openalex.org/W2901719664","https://openalex.org/W2901856936","https://openalex.org/W2904016068","https://openalex.org/W2906682542","https://openalex.org/W2911380795","https://openalex.org/W2945386002","https://openalex.org/W2946788828","https://openalex.org/W2953766590","https://openalex.org/W2967655665","https://openalex.org/W2979317446","https://openalex.org/W2992970636","https://openalex.org/W2995199710","https://openalex.org/W3005807752","https://openalex.org/W3015323970","https://openalex.org/W3087247858","https://openalex.org/W3093379611","https://openalex.org/W3121402667","https://openalex.org/W3169704229","https://openalex.org/W4247379612","https://openalex.org/W6685070821","https://openalex.org/W6734049434"],"related_works":["https://openalex.org/W2084156403","https://openalex.org/W2954753565","https://openalex.org/W3028283095","https://openalex.org/W2536781322","https://openalex.org/W7139990454","https://openalex.org/W4414544185","https://openalex.org/W3015330202","https://openalex.org/W2936162346","https://openalex.org/W4390542830","https://openalex.org/W3097068980"],"abstract_inverted_index":{"Bcl-2":[0,33,67,98],"family":[1,71,99],"anti-apoptotic":[2,95,297],"proteins":[3,298],"are":[4,56],"overexpressed":[5],"in":[6,118,119,126,130,194,218,265,280,283,302],"several":[7],"hematological":[8,39,48],"and":[9,12,18,61,85,100,125,136,150,158,173,204,211,215,221,226,245,273,282,309,312],"solid":[10,50],"tumors,":[11],"contribute":[13],"to":[14,20,27,90,111,146,197,258,288,305],"tumor":[15,212,267,315],"formation,":[16,214],"progression,":[17],"resistance":[19],"therapy.They":[21],"represent":[22],"a":[23,32,185,242,247],"promising":[24,294],"therapeutic":[25],"avenue":[26],"explore":[28],"for":[29,38,46],"cancer":[30,106,223],"treatment.Venetoclax,":[31],"inhibitor":[34],"is":[35,42],"currently":[36],"used":[37],"malignancies":[40],"or":[41,49,238],"undergoing":[43],"clinical":[44],"trials":[45],"either":[47,198],"tumors.Despite":[51],"these":[52],"progresses,":[53],"ongoing":[54],"efforts":[55],"focusing":[57],"on":[58],"the":[59,112,163,178,252,255,289,303],"identification":[60,290],"development":[62],"of":[63,94,97,105,168,231,254,269,291,296],"new":[64,92,142,293],"molecules":[65],"targeting":[66],"protein":[68],"and/or":[69],"other":[70],"members.Methods:":[72],"Machine":[73],"learning":[74],"guided":[75],"virtual":[76],"screening":[77,277],"followed":[78],"by":[79,261],"surface":[80],"plasmon":[81],"resonance,":[82],"molecular":[83],"docking":[84,154],"pharmacokinetic":[86,102],"analyses":[87],"were":[88,138],"performed":[89],"identify":[91],"inhibitors":[93,295],"members":[96],"their":[101],"profile.The":[103],"sensitivity":[104],"cells":[107],"from":[108],"different":[109,314],"origin":[110],"identified":[113,139],"compounds":[114,144,257],"was":[115],"evaluated":[116],"both":[117,202,270],"vitro":[120,281],"(cell":[121],"survival,":[122],"apoptosis,":[123],"autophagy)":[124],"vivo":[127,266,284],"(tumor":[128],"growth":[129,268],"nude":[131],"mice)":[132],"preclinical":[133],"models.Results:":[134],"IS20":[135,157,203,237],"IS21":[137,159,179,205],"as":[140],"potential":[141],"lead":[143],"able":[145],"bind":[147,161],"Bcl-2,":[148,171,307],"Bcl-xL":[149,172,308],"Mcl-1":[151,174,310],"recombinant":[152,306],"proteins.Molecular":[153],"investigation":[155],"indicated":[156],"could":[160],"into":[162],"Beclin-1":[164],"BH3":[165,199],"binding":[166,187,200,304],"site":[167],"wild":[169],"type":[170],"proteins.In":[175],"particular,":[176],"although":[177],"docked":[180],"conformation":[181],"did":[182],"not":[183],"show":[184],"unique":[186],"mode,":[188],"it":[189],"clearly":[190],"showed":[191],"its":[192],"ability":[193,210,253],"flexibly":[195],"adapting":[196],"sites.Moreover,":[201],"reduced":[206,264],"cell":[207],"viability,":[208],"clonogenic":[209],"sphere":[213],"induced":[216],"apoptosis":[217,260],"leukemic,":[219],"melanoma":[220,274],"lung":[222],"cells.Autophagosome":[224],"formation":[225],"maturation":[227],"assays":[228],"demonstrated":[229,251],"induction":[230],"autophagic":[232],"flux":[233],"after":[234],"treatment":[235],"with":[236,240,279,299],"IS21.Experiments":[239],"z-VAD-fmk,":[241],"pan-caspase":[243],"inhibitor,":[244,250],"chloroquine,":[246],"late-stage":[248],"autophagy":[249],"two":[256,292],"promote":[259],"autophagy.IS21":[262],"also":[263],"human":[271],"leukemia":[272],"models.Conclusion:":[275],"Virtual":[276],"coupled":[278],"experimental":[285],"data":[286],"led":[287],"good":[300],"efficacy":[301],"proteins,":[311],"against":[313],"histotypes.":[316]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4225877081","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-05-05T00:00:00"}
